ReNeuron Group to appoint administrators amid financial uncertainty
LONDON: ReNeuron Group plc, a pioneering UK-based biotechnology firm specializing in stem cell derived exosome technologies, has announced the board’s decision to appoint administrators. This move comes as a follow-up to the company’s previous announcement on 5 February 2024, which highlighted ongoing business development and financing discussions. Despite exhaustive efforts to explore various corporate strategies…